Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase

J Neurol Sci. 1972 Sep;17(1):45-51. doi: 10.1016/0022-510x(72)90021-4.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Carboxy-Lyases / antagonists & inhibitors*
  • Clinical Trials as Topic
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / blood*
  • Humans
  • Hydrazines / therapeutic use
  • Male
  • Methyldopa / therapeutic use
  • Movement Disorders / chemically induced*
  • Movement Disorders / drug therapy
  • Parkinson Disease / drug therapy*

Substances

  • Hydrazines
  • Methyldopa
  • Dihydroxyphenylalanine
  • Carboxy-Lyases